1. Home
  2. QNRX vs GGRP Comparison

QNRX vs GGRP Comparison

Compare QNRX & GGRP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Quoin Pharmaceuticals Ltd.

QNRX

Quoin Pharmaceuticals Ltd.

HOLD

Current Price

$8.16

Market Cap

14.5M

Sector

Health Care

ML Signal

HOLD

Logo The Glimpse Group Inc. Common Stock

GGRP

The Glimpse Group Inc. Common Stock

N/A

Current Price

$0.59

Market Cap

12.0M

Sector

Technology

ML Signal

N/A

Company Overview

Basic Information
Metric
QNRX
GGRP
Founded
2018
2016
Country
United States
United States
Employees
N/A
40
Industry
Medical/Dental Instruments
EDP Services
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
14.5M
12.0M
IPO Year
2023
2021

Fundamental Metrics

Financial Performance
Metric
QNRX
GGRP
Price
$8.16
$0.59
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
14.0K
51.2K
Earning Date
05-12-2026
05-15-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$72.00
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.21
$0.54
52 Week High
$41.80
$0.65

Technical Indicators

Market Signals
Indicator
QNRX
GGRP
Relative Strength Index (RSI) 45.27 42.80
Support Level $8.03 $0.55
Resistance Level $8.97 $0.64
Average True Range (ATR) 0.41 0.05
MACD 0.02 -0.01
Stochastic Oscillator 47.29 21.76

Price Performance

Historical Comparison
QNRX
GGRP

About QNRX Quoin Pharmaceuticals Ltd.

Quoin Pharmaceuticals Ltd is a clinical stage specialty pharmaceutical company focused on developing and commercializing therapeutic products that treat rare and orphan diseases. Its pipeline comprises three products that collectively have the potential to target a broad number of rare and orphan indications, including Netherton Syndrome, Peeling Skin Syndrome, Palmoplantar Keratoderma, Epidermolysis Bullosa, and others.

About GGRP The Glimpse Group Inc. Common Stock

The Glimpse Group Inc is a diversified immersive technology platform company, focused on providing enterprise solutions in virtual reality (VR), augmented reality (AR), and spatial computing. The company operates multiple subsidiaries that develop VR and AR software and services across various industries, including corporate training, education, healthcare, government, defense, marketing, retail, and financial services. It also offers AI-driven spatial computing platforms that support simulations, social VR, behavioral health, and corporate events. The Company reports its revenues in three categories: Software Services, Software License and Software-as-a-Service (SaaS), and Royalty Income, with the majority being from the Software Services category.

Share on Social Networks: